111 related articles for article (PubMed ID: 2820446)
1. Galactose clearance in patients with hepatocellular carcinoma. Evaluation of effective hepatic blood flow.
Meacci E; Smorlesi C; Chiarantini E; Birardi A; Buzzelli G
Boll Soc Ital Biol Sper; 1987 Jun; 63(6):489-95. PubMed ID: 2820446
[No Abstract] [Full Text] [Related]
2. Galactose loading tests in patients with hepatocellular carcinoma for the assessment of chemotherapy.
Buzzelli G; Meacci E; Smorlesi C; Chiarantini E; Birardi A; Gentilini P
Chemioterapia; 1987 Aug; 6(4):306-9. PubMed ID: 2820595
[TBL] [Abstract][Full Text] [Related]
3. Correlation of liver function and structure of cirrhosis with and without hepatoma based on autopsy studies.
Sakurai M; Miyaji T
Acta Pathol Jpn; 1971 Nov; 21(4):531-9. PubMed ID: 4340723
[No Abstract] [Full Text] [Related]
4. Intrahepatic arteriovenous shunting due to hepatocellular carcinoma and cirrhosis, and its change by transcatheter arterial embolization.
Sugano S; Miyoshi K; Suzuki T; Kawafune T; Kubota M
Am J Gastroenterol; 1994 Feb; 89(2):184-8. PubMed ID: 8304300
[TBL] [Abstract][Full Text] [Related]
5. The afferent circulation of the liver in patients with primary hepatocellular carcinoma.
Jakab F; Ráth Z; Schmal F; Nagy P; Faller J
Hepatogastroenterology; 1995; 42(4):399-402. PubMed ID: 8586376
[TBL] [Abstract][Full Text] [Related]
6. Hepatic resection for hepatocellular carcinoma existing with liver cirrhosis.
Ezaki T; Yamamoto K; Yamaguchi H; Sasaki Y; Ishida T; Mori M; Aimitsu S
Hepatogastroenterology; 2002; 49(47):1363-8. PubMed ID: 12239943
[TBL] [Abstract][Full Text] [Related]
7. Effective liver blood flow: determination by galactose clearance.
Henderson JM; Hanna SS
Can J Surg; 1983 Mar; 26(2):129-32. PubMed ID: 6824999
[TBL] [Abstract][Full Text] [Related]
8. ["Partial wrapping therapy" for recurrent hepatocellular carcinoma by transthoracic route].
Masutani S; Sasaki Y; Imaoka S; Kishimoto S; Iwamoto S; Nakamori S; Ohigashi H; Kameyama M; Hiratsuka M; Ishikawa O
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1489-91. PubMed ID: 8396902
[TBL] [Abstract][Full Text] [Related]
9. [Primary liver carcinoma a clinical study].
Rostock KJ; Claus R
Dtsch Z Verdau Stoffwechselkr; 1973; 33(4):193-8. PubMed ID: 4365202
[No Abstract] [Full Text] [Related]
10. [Differential diagnosis and pathophysiologic principles of ascites].
Paumgartner G; Gerbes AL
Chirurg; 1993 Jan; 64(1):1-6. PubMed ID: 8382146
[No Abstract] [Full Text] [Related]
11. Topical cooling-assisted hepatic segmentectomy for cirrhotic liver with hepatocellular carcinoma.
Yamanaka N; Furukawa K; Tanaka T; Tanaka W; Yamanaka J; Imakita M; Okamoto E
J Am Coll Surg; 1997 Mar; 184(3):290-6. PubMed ID: 9060927
[TBL] [Abstract][Full Text] [Related]
12. Serum selenium concentration in patients with liver cirrhosis and hepatocellular carcinoma.
Buljevac M; Romić Z; Vucelić B; Banić M; Krznarić Z; Plesko S
Acta Med Croatica; 1996; 50(1):11-4. PubMed ID: 8776109
[TBL] [Abstract][Full Text] [Related]
13. Is the incidence of intrahepatic multicentric recurrence of hepatocellular carcinoma more frequent in "the carcinogenic stage" than in liver cirrhosis?
Izumi N
J Gastroenterol; 2003; 38(9):918-20. PubMed ID: 14564643
[No Abstract] [Full Text] [Related]
14. [Evaluation of antipyrine clearance in chronic liver diseases].
Wang JL; Zhang F; Yuan SY
Zhonghua Nei Ke Za Zhi; 1989 May; 28(5):295-7, 315-6. PubMed ID: 2553353
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of liver reserve function by ICGR15 detection before hepatectomy for hepatocellular carcinoma].
Lao XM; Zhang YQ; Guan YX; Guo RP; Lin XJ; Yuan YF; Li JQ; Li GH
Ai Zheng; 2004 Oct; 23(10):1213-7. PubMed ID: 15473939
[TBL] [Abstract][Full Text] [Related]
16. Model for End-stage Liver Disease score fails to predict perioperative outcome after hepatic resection for hepatocellular carcinoma in patients without cirrhosis.
Teh SH; Sheppard BC; Schwartz J; Orloff SL
Am J Surg; 2008 May; 195(5):697-701. PubMed ID: 18367132
[TBL] [Abstract][Full Text] [Related]
17. [Hepatocellular carcinoma with cirrhosis: treatment with doxorubicin. Phase II evaluation].
Barbare JC; Ballet F; Petit J; Poupon R; Darnis F
Bull Cancer; 1984; 71(5):442-5. PubMed ID: 6084528
[TBL] [Abstract][Full Text] [Related]
18. Recovery from liver failure after hepatectomy for hepatocellular carcinoma in cirrhosis: meaning of the model for end-stage liver disease.
Cucchetti A; Ercolani G; Cescon M; Ravaioli M; Zanello M; Del Gaudio M; Lauro A; Vivarelli M; Grazi GL; Pinna AD
J Am Coll Surg; 2006 Nov; 203(5):670-6. PubMed ID: 17084328
[TBL] [Abstract][Full Text] [Related]
19. Hepatic parenchymal cell volume and the indocyanine green tolerance test.
Hashimoto M; Watanabe G
J Surg Res; 2000 Aug; 92(2):222-7. PubMed ID: 10896825
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous regression of hepatocellular carcinoma in a cirrhotic patient: possible vascular hypothesis.
Bastawrous S; Kogut MJ; Bhargava P
Singapore Med J; 2012 Oct; 53(10):e218-21. PubMed ID: 23112034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
